News
Tour de France stage five: Evenepoel’s exhibition, Pogacar into yellow, nightmare day for Vingegaard
Analysis of the fifth stage of the 2025 Tour de France, a 33km time trial starting and finishing in the city of Caen ...
Denmark's Jonas Vingegaard (Visma-Lease a Bike) lost over a minute on Slovenia's Tadej Pogacar (UAE Team Emirates-XRG), who ...
Remco Evenepoel won the stage five time trial at the Tour de France as Tadej Pogacar seized yellow and saw his rival Jonas ...
Grippy nubbins are how Prologo managed to make their wild aero carbon Predator 01TT CPC saddle even more expensive, so Jonas ...
Dane looks ahead to the mountains on stage 10 and into the second and third week, as he sits fourth on GC 1:17 behind close ...
Jasper Philipsen powered to victory in a reduced bunch sprint to claim his 10th career Tour de France stage win and seize the ...
Explore more
The Visma-Lease a Bike team of Jonas Vingegaard were the protagonists, with several contenders for the overall classification ...
13h
Cycling News on MSNWhy is Jonas Vingegaard the only rider on his team to wear a red helmet at the Tour de France?The only other rider on the team to wear a different helmet is, of course, Wout Van Aert, who wears a helmet painted in ...
Jonas Vingegaard's wife Trine was brutally honest in her assessment of the Visma-Lease cycling team, as she blamed them for ...
6h
Cyclingnews on MSN'Why is Visma racing like that?' - Former Tour de France winner Bjarne Riis blasts stage 6 strategy used by Jonas Vingegaard's squadFormer Danish rider and team director slams Wout van Aert's breakaway performacne, argues Visma and Vingegaard need to change ...
5h
Cyclingnews on MSN'We think Jonas will open up the gaps in the Alps' – Sepp Kuss upbeat about team leader Vingegaard's chances in Tour de France third weekVuelta a España winner his says support work for Visma-Lease a Bike GC challenge will start on ultra-hilly stage 10 ...
A fourth Tour win will draw Pogačar level with British rider Chris Froome for the fifth-most wins of all time. Merckx, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results